Lupus glomerulonephritis is a common and serious complication of systemic lupus erythematosus (SLE) affecting up to 50% of lupus patients. Recurrent lupus nephritis is rare, complicating as low as 1% of the lupus transplant population according to some authors. However, it may be underreported with more realistic recurrent rates oscillating from 2.8 to 8.7%. We report the case of a patient with SLE who lost her first allograft 4 years after transplantation with a diagnosis of de novo fibrillary glomerulopathy. She underwent a second renal transplantation and her renal function was stable for the past 5 years. She now presented with skin rash, arthralgias and positive lupus serologies. Her creatinine was slightly elevated and proteinuria was also noted. A renal biopsy performed revealed a recurrent focal proliferative lupus nephritis (WHO III). Retrospectively, we believe that her first allograft was also lost to recurrent lupus nephritis. This is a unique case of recurrent lupus nephritis in the second allograft of a patient with SLE.

Keywords:
Allograft, Lupus, Recurrent
1.
Stone JH, Amend WJ, Criswell LA: End-stage renal disease. Lupus patients may be particularly susceptible to adverse events occurring in the first year after transplantation. Further investigation is needed to improve renal transplantation outcomes for patients with lupus. Semin Arthritis Rheum 1997;27:18–26.
2.
Stone JH: End-stage renal disease in lupus: Disease activity, dialysis, and the outcome of transplantation. Lupus 1998;7:654–659.
3.
Mojcik CF, Klippel JH: End-stage renal disease and systemic lupus erythematosus. Am J Med 1996;101:100–107.
4.
Hariharan S, Peddi VR, Savin VJ, Johnson CP, First MR, Roza AM, Adams MB: Recurrent and de novo renal disease after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 1998;31:928–931.
5.
Mathew TH: Recurrence of disease following renal transplantation. Am J Kidney Dis 1998;12:85–96.
6.
Ramos EL, Tisher CC: Recurrent diseases in the kidney transplant. Am J Kidney Dis 1994;24:142–154.
7.
Russel R: Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 1998;41:678–686.
8.
Colvin RB: Heptinstall’s Pathology of the Kidney: Renal Transplant Pathology. Philadelphia, Lippincott-Raven, 1998, pp 1409–1540.
9.
Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DE, Fryd DS, Aschner NL, Simmons RL, Najarian JS: Single-center 1–15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation 1988;46:703–709.
10.
Isaac J, Herrera GA, Shihab FS: De novo fibrillary glomerulopathy in the renal allograft of a patient with systemic lupus erythematosus. Nephron 2001;87:365–368.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.